Page last updated: 2024-10-29

isocarboxazid and Asthma

isocarboxazid has been researched along with Asthma in 1 studies

Isocarboxazid: An MAO inhibitor that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in the treatment of panic disorder and the phobic disorders. (From AMA, Drug Evaluations Annual, 1994, p311)

Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
GRILLIAT, JP1
ANTOINE, F1
SAPELIER, P1
RASPILLER, A1

Other Studies

1 other study available for isocarboxazid and Asthma

ArticleYear
[Notes on the treatment of angina pectoris with a new monoamine oxidase inhibitor (M.A.O.I.)].
    Annales medicales de Nancy, 1962, Volume: 1

    Topics: Angina Pectoris; Asthma; Humans; Isocarboxazid; Monoamine Oxidase Inhibitors

1962